{
  "id": "0d6cc0ee9f93f7ac",
  "title": "STAT+: Lilly\u2019s next-gen obesity drug delivers major weight loss in Phase 3 trial, but with many discontinuations",
  "description": "Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.",
  "content": "Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/11/eli-lilly-retatrutide-weight-loss-obesity-tolerability-trial-results/?utm_campaign=rss",
  "published_at": "2025-12-11T11:45:00+00:00",
  "fetched_at": "2025-12-12T00:22:56.348095+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Lilly\u2019s next-gen obesity drug delivers major weight loss in Phase 3 trial, but with many discontinuations",
    "description": "Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.",
    "url": "https://www.statnews.com/2025/12/11/eli-lilly-retatrutide-weight-loss-obesity-tolerability-trial-results/?utm_campaign=rss",
    "published": "2025-12-11T11:45:00+00:00",
    "source": "STAT"
  }
}